The Valley Desk

NCT01397201 · Interventional trial

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Overall registry status Terminated

Phase 2

Conditions Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov